GB201511246D0 - Pharmaceutical formulation - Google Patents
Pharmaceutical formulationInfo
- Publication number
- GB201511246D0 GB201511246D0 GBGB1511246.9A GB201511246A GB201511246D0 GB 201511246 D0 GB201511246 D0 GB 201511246D0 GB 201511246 A GB201511246 A GB 201511246A GB 201511246 D0 GB201511246 D0 GB 201511246D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- pharmaceutical formulation
- formulation
- pharmaceutical
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1511246.9A GB201511246D0 (en) | 2015-06-25 | 2015-06-25 | Pharmaceutical formulation |
| PCT/EP2016/064889 WO2016207443A1 (en) | 2015-06-25 | 2016-06-27 | Pharmaceutical composition comprising pemetrexed |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1511246.9A GB201511246D0 (en) | 2015-06-25 | 2015-06-25 | Pharmaceutical formulation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB201511246D0 true GB201511246D0 (en) | 2015-08-12 |
Family
ID=53872263
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GBGB1511246.9A Ceased GB201511246D0 (en) | 2015-06-25 | 2015-06-25 | Pharmaceutical formulation |
Country Status (2)
| Country | Link |
|---|---|
| GB (1) | GB201511246D0 (en) |
| WO (1) | WO2016207443A1 (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2020222151A1 (en) * | 2019-05-01 | 2020-11-05 | Intas Pharmaceuticals Ltd. | A stable, ready to use aqueous pharmaceutical composition of pemetrexed |
| WO2021192472A1 (en) * | 2020-03-24 | 2021-09-30 | ナガセ医薬品株式会社 | Pemetrexed formulation |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SI2854768T1 (en) * | 2012-05-30 | 2017-08-31 | Fresenius Kabi Oncology Limited | Pharmaceutical compositions of pemetrexed |
| EP2953616A2 (en) * | 2013-02-06 | 2015-12-16 | Cipla House | Pemetrexed complexes and pharmaceutical compositions containing pemetrexed complexes |
| WO2014167585A1 (en) * | 2013-04-12 | 2014-10-16 | Actavis Group Ptc Ehf. | Pemetrexed formulation |
| WO2014198337A1 (en) * | 2013-06-14 | 2014-12-18 | Synthon B.V. | Stable and water soluble pharmaceutical compositions comprising pemetrexed |
-
2015
- 2015-06-25 GB GBGB1511246.9A patent/GB201511246D0/en not_active Ceased
-
2016
- 2016-06-27 WO PCT/EP2016/064889 patent/WO2016207443A1/en active Application Filing
Also Published As
| Publication number | Publication date |
|---|---|
| WO2016207443A1 (en) | 2016-12-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1254343A1 (en) | Pharmaceutical formulations | |
| SI4070787T1 (en) | Pharmaceutical formulations | |
| IL271226A (en) | Pharmaceutical formulation | |
| PT3426294T (en) | Pharmaceutical formulation | |
| IL253177B (en) | Pharmaceutical formulation | |
| HK1245653A1 (en) | Pharmaceutical formulation | |
| ZA201707094B (en) | Pharmaceutical formulations | |
| IL266537A (en) | Pharmaceutical formulation | |
| ZA201807851B (en) | Pharmaceutical formulation | |
| FI3601277T3 (en) | Pharmaceutical formulation | |
| GB201506755D0 (en) | Novel pharmaceutical formulation | |
| GB201511246D0 (en) | Pharmaceutical formulation | |
| IL275144A (en) | Pharmaceutical formulation | |
| GB201719873D0 (en) | Pharmaceutical formulation | |
| GB201604545D0 (en) | Novel pharmaceutical formulation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AT | Applications terminated before publication under section 16(1) |